Terms: = Ovarian cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Treatment
62 results:
1. Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target.
Li W; Huang L; Qi N; Zhang Q; Qin Z
BMC Genomics; 2024 Feb; 25(1):183. PubMed ID: 38365611
[TBL] [Abstract] [Full Text] [Related]
2. ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study.
Gizaw M; Parkin DM; Stöter O; Bukirwa P; Seife E; Chesumbai G; Korir A; Liu B; Manraj SS; Nda G; Somdyala NIM; Kantelhardt EJ
Int J Cancer; 2024 Jun; 154(11):1911-1919. PubMed ID: 38339849
[TBL] [Abstract] [Full Text] [Related]
3. Closing the diagnostic gap: Liquid biopsy potential to transform ovarian cancer outcomes in sub-Saharan Africa.
Kokori E; Olatunji G; Ogieuhi IJ; Muogbo I; Isarinade D; Ukoaka B; Ajayi I; Ezenwoba C; Samuel O; Nurudeen-Busari H; Olawade DB; Aderinto N
Medicine (Baltimore); 2024 Feb; 103(5):e37154. PubMed ID: 38306573
[TBL] [Abstract] [Full Text] [Related]
4. Radiolabelled
Cieslik PA; Klingler S; Nolff M; Holland JP
Chemistry; 2024 Mar; 30(14):e202303805. PubMed ID: 38064536
[TBL] [Abstract] [Full Text] [Related]
5. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in ovarian cancer Cells and a Transgenic Mouse Model of ovarian cancer.
Huang Y; Fan Y; Zhao Z; Zhang X; Tucker K; Staley A; Suo H; Sun W; Shen X; Deng B; Pierce SR; West L; Yin Y; Emanuele MJ; Zhou C; Bae-Jump V
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569750
[TBL] [Abstract] [Full Text] [Related]
7. Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis.
Gong W; Yu R; Cao C; Fang Y; Zhao X; Gao Q
J Ovarian Res; 2023 Jul; 16(1):136. PubMed ID: 37430376
[TBL] [Abstract] [Full Text] [Related]
8. Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors.
Mulders MCF; de Lussanet de la Sablonière QG; van Velthuysen MLF; Roes EM; Hofland J; de Herder WW
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37140986
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer.
Christodoulaki A; He H; Zhou M; Cardona Barberán A; De Roo C; Chuva De Sousa Lopes SM; Baetens M; Menten B; Van Soom A; De Sutter P; Weyers S; Boel A; Stoop D; Heindryckx B
Hum Reprod; 2023 Jun; 38(6):1135-1150. PubMed ID: 37029914
[TBL] [Abstract] [Full Text] [Related]
10. Trends in the incidence of ovarian cancer in sub-Saharan Africa.
Gizaw M; Parkin DM; Stöter O; Korir A; Kamate B; Liu B; Bojang L; N'Da G; Manraj SS; Bukirwa P; Chokunonga E; Chingonzoh T; Peko JF; Finesse A; Somdyala N; Ladipo A; Kantelhardt EJ
Int J Cancer; 2023 Apr; 152(7):1328-1336. PubMed ID: 36274630
[TBL] [Abstract] [Full Text] [Related]
11. Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis.
Liu X; Yue J; Pervaiz R; Zhang H; Wang L
Front Endocrinol (Lausanne); 2022; 13():986477. PubMed ID: 36176466
[TBL] [Abstract] [Full Text] [Related]
12. Is Adnexectomy Mandatory at the Time of Hysterectomy for Uterine Sarcomas? A Systematic Review and Meta-Analysis.
Ronsini C; Foresta A; Giudice M; Reino A; La Verde M; Della Corte L; Bifulco G; Franciscis P; Cianci S; Capozzi VA
Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143817
[No Abstract] [Full Text] [Related]
13. Access to and Affordability of World Health Organization Essential Medicines for cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
[TBL] [Abstract] [Full Text] [Related]
14. Clinical features, treatments, and outcomes of patients with anti-
Xu Q; Zhu Y; Wang Q; Han J; Mao F; Zeng S; Chen S; Zhao C; Gu M; Li Z; Luo X; Fu X; Huang Y
Front Biosci (Landmark Ed); 2021 Sep; 26(9):496-503. PubMed ID: 34590462
[No Abstract] [Full Text] [Related]
15. Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.
Wenzel L; Huang HQ; Cella D; McKinney CO; Zevon MA; LaChance JA; Walker JL; Salani R; Modesitt SC; Morris RT; Bradley WH; Boente MP; von Gruenigen VE
Gynecol Oncol; 2021 Nov; 163(2):392-397. PubMed ID: 34548162
[TBL] [Abstract] [Full Text] [Related]
16. Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
Al-Mugotir M; Lovelace JJ; George J; Bessho M; Pal D; Struble L; Kolar C; Rana S; Natarajan A; Bessho T; Borgstahl GEO
PLoS One; 2021; 16(3):e0248941. PubMed ID: 33784323
[TBL] [Abstract] [Full Text] [Related]
17. A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial ovarian cancer.
Cui Q; Hu Y; Ma D; Liu H
Drug Des Devel Ther; 2021; 15():339-347. PubMed ID: 33536747
[TBL] [Abstract] [Full Text] [Related]
18. Feasibility of neoadjuvant and adjuvant intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer: A single-center experience.
Liu Y; Cao L; Chen W; Wang J; Wang W; Liang Z
Medicine (Baltimore); 2020 Sep; 99(36):e22100. PubMed ID: 32899091
[TBL] [Abstract] [Full Text] [Related]
19. Paclitaxel Induces Immunogenic Cell Death in ovarian cancer via TLR4/IKK2/SNARE-Dependent Exocytosis.
Lau TS; Chan LKY; Man GCW; Wong CH; Lee JHS; Yim SF; Cheung TH; McNeish IA; Kwong J
Cancer Immunol Res; 2020 Aug; 8(8):1099-1111. PubMed ID: 32354736
[TBL] [Abstract] [Full Text] [Related]
20. Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with
Cędrowska E; Pruszyński M; Gawęda W; Żuk M; Krysiński P; Bruchertseifer F; Morgenstern A; Karageorgou MA; Bouziotis P; Bilewicz A
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106568
[TBL] [Abstract] [Full Text] [Related]
[Next]
